RBM15 may have a function as an oncogene in lung adenocarcinoma, according to relevant publications (Li et al., 2020); Su, Huang & Hu (2019) discovered that RBM15 may contribute to the malignant evolution of GC and alter clinical prognosis. This evidence concerns the gene RBM15 and lung adenocarcinoma.